Abstract
Bendamustine, a drug originally developed more than 50 years ago, has only recently been established as standard of care especially in elderly and medically unfit patients with lymphoproliferative ...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
